➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Express Scripts
McKesson
Harvard Business School
Merck

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent: 10,466,163

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,466,163
Title:Concurrently evaluating assays with optical inhomogeneities
Abstract: During an assay, optical measurements are made at a sensing surface (112), and at least one \"homogeneity-image\" of the sensing surface (112) is generated. From this image, an \"homogeneity-indicator\" is determined for at least one region of interest, and the optical measurements are then evaluated in dependence on said indicator. The homogeneity-indicator may for example be a binary value which indicates if an inhomogeneity was detected or not. If an inhomogeneity was detected, all optical measurements may be rejected, only measurements for the involved region of interest may be rejected, or measurements for a selected sub-area of the involved region of interest (ROI) may be rejected.
Inventor(s): Evers; Toon Hendrik (Eindhoven, NL), Klunder; Derk Jan Wilfred (Geldrop, NL), Nieuwenhuis; Jeroen Hans (Waalre, NL), Van Zon; Joannes Baptist Adrianus Dionisius (Waalre, NL)
Assignee: KONINKLIJKE PHILIPS N.V. (Eindhoven, NL)
Application Number:14/113,964
Patent Claims:see list of patent claims

Details for Patent 10,466,163

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial KONINKLIJKE PHILIPS N.V. (Eindhoven, NL) 2031-04-28 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial KONINKLIJKE PHILIPS N.V. (Eindhoven, NL) 2031-04-28 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial KONINKLIJKE PHILIPS N.V. (Eindhoven, NL) 2031-04-28 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial KONINKLIJKE PHILIPS N.V. (Eindhoven, NL) 2031-04-28 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Mallinckrodt
Boehringer Ingelheim
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.